Company / Interest Expense
STANDARD BIOTOOLS INC. Interest Expense History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$4.3M
FY2023
5-year range
$3.8M / $4.3M
FY2019-FY2023
Trend
+13.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense returned to growth in FY2023 after 2 years of decline, reaching $4M.
Based on SEC 10-K filings.
$4M in FY2023 with a 5-year CAGR of -5.7%.
Remained stable around $4M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -32.2%
- 5-Year CAGR
- -5.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -5.7%, indicating a declining trend.
- In FY2023, interest expense increased 13.3% year-over-year.
- Peak interest expense was recorded in FY2020.
- Lowest interest expense in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $4.3M | +13.3% |
| FY2022 | $3.8M | -10.7% |
| FY2021 | $4.3M | -69.2% |
| FY2020 | $13.9M | +138.5% |
| FY2019 | $5.8M | +0.1% |
| FY2018 | $5.8M | +0.2% |
| FY2017 | $5.8M | +8.7% |
| FY2016 | $5.3M | +38071.4% |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026